Avantax Planning Partners, Inc. Enanta Pharmaceuticals Inc Transaction History

Avantax Planning Partners, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$65.41 - $84.65 $32,705 - $42,325	-500 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$85.46 - $126.37 $42,730 - $63,185	500 New	500 $43,000
Q2 2018 Aug 13, 2018	SELL	$81.85 - $120.51 $4,256 - $6,266	-52 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$57.91 - $92.15 $3,011 - $4,791	52 New	52 $4,000

108

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $109M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Avantax Planning Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Avantax Planning Partners, Inc. with notifications on news.